Literature DB >> 12161026

Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development.

Georges J M Maestroni1.   

Abstract

The information gathered by dendritic cells (DC) during the innate immune response to a pathogen is determinant for the type of adaptive response. Here we show that short-term (3 h) exposure of bone marrow-derived DC to norepinephrine (NE), at the beginning of lipopolysaccharide (LPS) or keyhole limpet hemocyanin (KLH) stimulation hampers IL-12 production and increases IL-10 release. The NE effect was mediated by both beta- and alpha2-adrenergic receptors. The capacity of NE-exposed DC to produce IL-12 upon CD40 cross-linking as well as to stimulate allogeneic T-helper (Th) lymphocytes was reduced. Adoptive transfer of NE-exposed DC induced a Th2 slanted response in vivo. Thus, a brief NE exposure of antigen-stimulated DC seems to limit their Th1 polarizing properties. Noteworthy, the ganglionic blocker pentolinium administered in mice before skin sensitization with fluoroscein isothiocyanate (FITC) could increase the Th1-type response in the draining lymph nodes. Our results suggest that the extent of Th differentiation in the response to an antigen might be influenced by the local sympathetic nervous activity in the early phase of dendritic cell stimulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161026     DOI: 10.1016/s0165-5728(02)00188-1

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  15 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

Review 2.  Neuroimmune interactions: dendritic cell modulation by the sympathetic nervous system.

Authors:  Maisa C Takenaka; Marcia G Guereschi; Alexandre S Basso
Journal:  Semin Immunopathol       Date:  2016-10-31       Impact factor: 9.623

3.  Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells.

Authors:  Byung-Jin Kim; Harlan P Jones
Journal:  Brain Behav Immun       Date:  2010-05-31       Impact factor: 7.217

4.  THE MULTIFACETED ROLE OF T CELL-MEDIATED IMMUNITY IN PATHOGENESIS AND RESISTANCE TO MYCOPLASMA RESPIRATORY DISEASE.

Authors:  Nicole A Dobbs; Adam N Odeh; Xiangle Sun; Jerry W Simecka
Journal:  Curr Trends Immunol       Date:  2009

Review 5.  Role of peripheral nerve fibres in acute and chronic inflammation in arthritis.

Authors:  Georg Pongratz; Rainer H Straub
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

Review 6.  Catecholamines, steroids and immune alterations in ischemic stroke and other acute diseases.

Authors:  Juliane Schulze; Antje Vogelgesang; Alexander Dressel
Journal:  Aging Dis       Date:  2014-10-01       Impact factor: 6.745

7.  β2-Adrenergic agonists bias TLR-2 and NOD2 activated dendritic cells towards inducing an IL-17 immune response.

Authors:  Michela Manni; Richard D Granstein; Georges Maestroni
Journal:  Cytokine       Date:  2011-06-16       Impact factor: 3.861

Review 8.  Divergent neuroendocrine responses to localized and systemic inflammation.

Authors:  Mark K Lukewich; Richard C Rogers; Alan E Lomax
Journal:  Semin Immunol       Date:  2014-01-31       Impact factor: 11.130

9.  Sympathetic nervous system control of anti-influenza CD8+ T cell responses.

Authors:  Kristie M Grebe; Heather D Hickman; Kari R Irvine; Kazuyo Takeda; Jack R Bennink; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-13       Impact factor: 11.205

10.  Diversity of interferon gamma and granulocyte-macrophage colony-stimulating factor in restoring immune dysfunction of dendritic cells and macrophages during polymicrobial sepsis.

Authors:  Stefanie B Flohé; Hemant Agrawal; Sascha Flohé; Meenakshi Rani; Jörg M Bangen; F Ulrich Schade
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.